RYESX | VENAX | RYESX / VENAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 20 years | - |
Gain YTD | 9.608 | 9.635 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 100000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.5M | 9.25B | 0% |
Annual Yield % from dividends | 0.00 | 2.93 | - |
Returns for 1 year | 8.73 | 19.80 | 44% |
Returns for 3 years | 30.58 | 49.05 | 62% |
Returns for 5 years | 15.76 | 68.26 | 23% |
Returns for 10 years | -56.86 | 26.46 | -215% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
KCISX | 12.46 | 0.06 | +0.48% |
Knights of Columbus International Eq S | |||
MIQBX | 10.33 | 0.04 | +0.39% |
Morgan Stanley Inst International Eq A | |||
HEMIX | 9.18 | 0.03 | +0.33% |
Janus Henderson Emerging Markets I | |||
SVAIX | 6.01 | N/A | N/A |
Federated Hermes Strategic Value Div IS | |||
MBVKX | 19.19 | N/A | N/A |
BlackRock Large Cap Focus Value K |